Tobacco displays in close proximity and in the same visual field with sweets.

<p>Tobacco displays in close proximity and in the same visual field with sweets.</p

Price ranges, average undiscounted and pricemarked price, discount in pence and as a percent of undiscounted price, number of packs on display and the proportion of pricemarked packs for the most commonly displayed 20-pack brands or similarly priced brand variants, ranked in descending undiscounted price order (NA = not available or not applicable).

<p>Price ranges, average undiscounted and pricemarked price, discount in pence and as a percent of undiscounted price, number of packs on display and the proportion of pricemarked packs for the most commonly displayed 20-pack brands or similarly priced brand variants, ranked in descending undiscounted price order (NA = not available or not applicable).</p

Examples of price-marked cigarette packs.

<p>Examples of price-marked cigarette packs.</p

Additional file 2: of Vape shops: who uses them and what do they do?

Customer questionnaire. (DOC 413 kb

Additional file 1: of Vape shops: who uses them and what do they do?

Shop questionnaire. (DOC 321 kb

Additional file 1: of Carlsberg alibi marketing in the UEFA euro 2016 football finals: implications of Probably inappropriate alcohol advertising

Table S1. Gross and Per Capita Impressions of Cumulative Carlsberg Alibi Appearances by Type, Match and Match period (population 4 to 17 year old). Table S2. Gross and Per Capita Impressions of Cumulative Carlsberg Alibi Appearances by Type, Match and Match period (population 18 years and older). (DOCX 19 kb

Univariate and multivariate analysis of rhinitis in relation to early and lifetime use of paracetamol up to the age of 5.

<p>*ORs adjusted for child's gender, area of residence and maternal education.</p>†<p>ORs adjusted for child's gender, area of residence and maternal education and additionally adjusted for symptoms of respiratory infections in the first year of life (and for cross-sectional analysis reported infection at year 5).</p>‡<p>Overall p-value (likelihood ratio test).</p>¶<p>P value for trend computed for dose of paracetamol use in the past month: low exposure (never reported use in the past month), medium exposure (use in past month at age 1 & 3), high exposure (use in past month at both time points).</p>¥<p>P value for trend as dose of paracetamol computed using a composite score of paracetamol exposure from yr 1, 3 and 5.</p>£<p>Early life paracetamol use: refers to use prior to the disease outcomes (i.e. first three years of life).</p>∑<p>Early life paracetamol dose: refers to dose of exposure in past month in first three years of life prior to disease outcomes.</p>β<p>Lifetime paracetamol use: refers to use of paracetamol up to the age of 5 (i.e. ages 1, 3 and 5).</p>±<p>Lifetime paracetamol dose: refers to dose of paracetamol exposure up to the age of 5 (i.e. ages 1, 3 and 5).</p

Univariate and multivariate analysis of sensitization in relation to early and lifetime use of paracetamol up to the age of 5.

<p>*ORs adjusted for child's gender, area of residence and maternal education.</p>†<p>ORs adjusted for child's gender, area of residence and maternal education and additionally adjusted for symptoms of respiratory infections in the first year of life (and for cross-sectional analysis reported infection at year 5).</p>‡<p>Overall p-value (likelihood ratio test).</p>¶<p>P value for trend computed for dose of paracetamol use in the past month: low exposure (never reported use in the past month), medium exposure (use in past month at age 1 3), high exposure (use in past month at both time points).</p>¥<p>P value for trend as dose of paracetamol computed using a composite score of paracetamol exposure from yr 1, 3 and 5.</p>£<p>Early life paracetamol use: refers to use prior to the disease outcomes (i.e. first three years of life).</p>∑<p>Early life paracetamol dose: refers to dose of exposure in past month in first three years of life prior to disease outcomes.</p>β<p>Lifetime paracetamol use: refers to use of paracetamol up to the age of 5 (i.e. ages 1, 3 and 5).</p>±<p>Lifetime paracetamol dose: refers to dose of paracetamol exposure up to the age of 5 (i.e. ages 1, 3 and 5).</p

OR for asthma, eczema, hay fever and sensitization in relation paracetamol use in the past month in women.

†<p>OR adjusted for age of the women, area of residence and women education.</p><p>*include asthma, eczema and hay fever.</p>¥<p>Sensitization to either <i>D</i>. <i>pteronyssinus</i> or cockroach allergen.</p>‡<p>Likelihood ratio test.</p>¶<p>P value for trend.</p

The birth cohort of women.

<p>The birth cohort of women.</p